RT Book, Section
A1 O'Donnell, James M.
A1 Shelton, Richard C.
A2 Brunton, Laurence L.
A2 Chabner, Bruce A.
A2 Knollmann, Björn C.
SR Print(0)
ID 1127866026
T1 Drug Therapy of Depression and Anxiety Disorders
T2 Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 12e
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 9780071624428
LK accessbiomedicalscience.mhmedical.com/content.aspx?aid=1127866026
RD 2023/09/24
AB Depression  and  anxiety  disorders  are  the  most  common  mental  illnesses,  each  affecting  in  excess  of  10-15%  of  the  population  at  some  time  in  their  lives.  Both  anxiety  and  depressive  disorders  are  amenable  to  pharmacological  treatments  that  have  been  developed  since  the  1950s.  With  the  discovery  of  more  selective  and  safer  drugs,  the  use  of  antidepressants  and  anxiolytics  has  moved  from  the  domain  of  psychiatry  to  other  medical  specialties,  including  primary  care.  The  relative  safety  of  the  majority  of  commonly  used  antidepressants  and  anxiolytics  notwithstanding,  their  optimal  use  requires  a  clear  understanding  of  their  mechanisms  of  action,  pharmacokinetics,  potential  drug  interactions,  and  the  differential  diagnosis  of  psychiatric  illnesses.